Rusan Pharma Limited, a active public limited company, was established on 15 March 1994 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1994PLC077069. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.84 Cr.
Formerly known as Rusan Pharma Private Limited. It upholds a compliant status. Employing 656 professional, Its leadership includes Kunal Navin Saxena (Managing Director), Balasaheb Annasaheb Patil (Director), Sandeep Verma (Director). Past directors included Dilipkumar Khandubhai Desai, Kunal Navin Saxena, Sandeep Verma. It holds ₹264.97 Cr open charges and ₹80.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 58-D, Government Industrial Estate Charkop, Kandivali West, Mumbai, Maharashtra, 400067.
U24230MH1994PLC077069
077069
15 March 1994
₹5.00 Cr
₹4.84 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rusan Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Navin Saxena | Managing Director | 05 Apr 2012 | Current |
| Balasaheb Annasaheb Patil | Director | 17 Oct 2012 | Current |
| Sandeep Verma | Director | 20 Mar 2023 | Current |
| Navin Satyapal Sexena | Director | 15 Mar 1994 | Current |
| Aakarsh Navin Saxena | Whole-Time Director | 10 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 May 2014 | Past |
| Pramod Abcsdd | Director | 05 May 2012 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Director | 19 Apr 2013 | Past |
| Pramod Abcsdd | Director | 01 May 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 15 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rusan Pharma Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.17% increase. The company also saw a substantial fall in profitability, with a 33.95% decrease in profit. The company's net worth Soared by an impressive increase of 18.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rusan Pharma had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary and 6 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,649,700,000.00
₹808,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2022 | Others | ₹10.00 Cr | Open |
| 27 Jul 2022 | Others | ₹10.00 Cr | Open |
| 31 Aug 2021 | Canara Bank | ₹75.00 Cr | Open |
| 29 Sep 2020 | Canara Bank | ₹16.50 Cr | Open |
| 23 May 2020 | Others | ₹16.50 Cr | Open |
Explore comprehensive loan charge details -
Rusan Pharma has a workforce of 656 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rusan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 21.00 Cr registered on 28 Dec 2015 with Charge ID 10614211 was modified on 25 Apr 2025. was recorded as a recent event.
Progress on Rusan Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Rusan Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge registered on 28 Jun 2016 via Charge ID 100042892 with Syndicate Bank was fully satisfied on 30 Jan 2024. was completed.
The activity A charge registered on 20 Jul 2020 via Charge ID 100504641 with Canara Bank was fully satisfied on 01 Jan 2024. was completed.
The activity Sandeep Verma was appointed as a Director was appointed as a Director on 20 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
The company said it has developed the drug, which would be available in the form of injections, pen and continuous infusion pumps, indigenously and has received approval from the Drug Controller General of India (DCGI). .
The CIN of Rusan Pharma Limited is U24230MH1994PLC077069.
Rusan Pharma Limited is headquartered at 58-D, Government Industrial Estate Charkop, Kandivali West, Mumbai, Maharashtra, 400067.
Rusan Pharma Limited was incorporated on 15 March 1994.
The current directors of Rusan Pharma Limited are
The primary industry of Rusan Pharma Limited is Manufacturing.
Rusan Pharma Limited is unlisted.
The authorized capital of Rusan Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹4.84 Cr.
The compliance status of Rusan Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX